Evidence map›Paper›PMID 41800897›Full record

ArticleMicrobiology spectrum2026

IS-Pro-based pathogen detection in explanted heart valves of suspected endocarditis patients.

Patricia Bartsch, Oliver Krebs, Christa Augustin, Martin Aepfelbacher, Holger Rohde, Benjamin Berinson

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patricia BartschInstitute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-6946-4757
Oliver KrebsInstitute of Legal Medicine, Center for Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christa AugustinInstitute of Legal Medicine, Center for Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Martin AepfelbacherInstitute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Holger RohdeInstitute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-8587-4433
Benjamin BerinsonInstitute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-2749-1201

Funding

Bundesministerium für. Forschung, Technologie und Raumfahrt 01KX2524InBiome
6 · The paper itself

Abstract

Accurate pathogen identification in infective endocarditis (IE) is limited, particularly in culture-negative cases. This study evaluated the performance of the Molecular Culture ID (MC-ID) assay in heart valve specimens from patients with suspected IE. Fifty-seven valve specimens from patients with suspected IE were analyzed using conventional culture, 16S/18S rDNA sequencing (SepsiTest, Molzym, Germany), the Biofire Joint Infection Panel (BJP; bioMérieux, Marcy l'Étoile, France), and MC-ID, with previously reported results as comparators. Twelve specimens (21.1%) were culture-positive, and 45 (78.9%) were culture-negative. MC-ID showed 83.3% positive agreement and 44.4% negative agreement with culture, achieving species-level concordance in 8/12 cases. Three culture-positive/MC-ID-negative results reflected organisms outside the assay's detection range or limited taxonomic resolution. MC-ID detected pathogens in 25/45 (55.5%) culture-negative specimens; 21 were corroborated by PCR and/or BJP. Discrepancies largely reflected polymicrobial infections or taxonomic resolution limits. MC-ID identified pathogens in four PCR-/BJP-negative specimens, of which three likely were of clinical significance. MC-ID was negative in two culture-negative, PCR-/BJP-positive specimens. MC-ID can improve pathogen detection in both culture-positive and culture-negative IE, complementing conventional and molecular diagnostics and providing a comprehensive microbiological assessment in suspected IE cases.IMPORTANCEInfective endocarditis (IE) remains difficult to diagnose, especially when blood and tissue cultures fail to identify a pathogen. Accurate organism detection is essential for guiding targeted therapy and reducing reliance on broad-spectrum antibiotics. This study shows that the Molecular Culture ID (MC-ID) assay markedly improves diagnostic yield in culture-negative valve specimens, frequently identifying pathogens missed by conventional and molecular tests. MC-ID also clarifies cases complicated by polymicrobial infection or limited taxonomic resolution, providing species-level or clinically actionable identification in many instances. By complementing existing diagnostic methods and expanding detection beyond their constraints, MC-ID offers a more comprehensive microbiological assessment of suspected endocarditis. Its integration into diagnostic workflows has the potential to enhance clinical decision-making and improve management of this high-risk condition.

Indexed as

BacteriaEndocarditisEndocarditis, BacterialHeart ValvesMolecular Diagnostic TechniquesDNA, BacterialFemaleHumansMaleMiddle AgedPolymerase Chain ReactionRNA, Ribosomal, 16SRNA, Ribosomal, 18SDNA, BacterialRNA, Ribosomal, 16SRNA, Ribosomal, 18S16S rDNA PCR syndromic panel PCRBiofire Film Array JI panelcultureinfectious endocarditisIS-Promolecular assayspathogen detection

Identifiers

PMID41800897
PMCPMC13055294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.